Jennifer E. Shook

1.6k total citations
30 papers, 1.3k citations indexed

About

Jennifer E. Shook is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Jennifer E. Shook has authored 30 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cellular and Molecular Neuroscience, 18 papers in Molecular Biology and 5 papers in Physiology. Recurrent topics in Jennifer E. Shook's work include Neuropeptides and Animal Physiology (18 papers), Pharmacological Receptor Mechanisms and Effects (9 papers) and Receptor Mechanisms and Signaling (8 papers). Jennifer E. Shook is often cited by papers focused on Neuropeptides and Animal Physiology (18 papers), Pharmacological Receptor Mechanisms and Effects (9 papers) and Receptor Mechanisms and Signaling (8 papers). Jennifer E. Shook collaborates with scholars based in United States. Jennifer E. Shook's co-authors include Thomas F. Burks, Victor J. Hruby, Enrico M. Camporesi, W. David Watkins, William S. Wire, John T. Pelton, William L. Dewey, Constance D. Lehman, Wieslaw M. Kazmierski and Thomas H. Kramer and has published in prestigious journals such as Gastroenterology, American Journal of Psychiatry and Biological Psychiatry.

In The Last Decade

Jennifer E. Shook

30 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer E. Shook United States 17 681 537 310 163 160 30 1.3k
José A. Terrón Spain 24 456 0.7× 537 1.0× 393 1.3× 102 0.6× 203 1.3× 102 1.8k
J. Wynants Belgium 13 492 0.7× 418 0.8× 118 0.4× 41 0.3× 59 0.4× 20 1.2k
A. de Jonge Netherlands 23 885 1.3× 1.3k 2.3× 528 1.7× 66 0.4× 39 0.2× 61 1.9k
J.P. McAuliff United States 8 531 0.8× 915 1.7× 525 1.7× 67 0.4× 28 0.2× 19 1.8k
J. F. Giudicelli France 20 216 0.3× 404 0.8× 268 0.9× 63 0.4× 32 0.2× 55 1.2k
Kouichiro Minami Japan 24 650 1.0× 639 1.2× 349 1.1× 35 0.2× 20 0.1× 87 1.7k
A. Arnold United States 9 552 0.8× 940 1.8× 539 1.7× 67 0.4× 27 0.2× 22 1.8k
J.L. Junien France 21 961 1.4× 1.2k 2.3× 381 1.2× 82 0.5× 15 0.1× 60 2.1k
S.K. Kulkarni India 20 357 0.5× 237 0.4× 124 0.4× 43 0.3× 108 0.7× 46 1.1k
A.M. Lands United States 12 701 1.0× 1.2k 2.3× 663 2.1× 81 0.5× 36 0.2× 32 2.4k

Countries citing papers authored by Jennifer E. Shook

Since Specialization
Citations

This map shows the geographic impact of Jennifer E. Shook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer E. Shook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer E. Shook more than expected).

Fields of papers citing papers by Jennifer E. Shook

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer E. Shook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer E. Shook. The network helps show where Jennifer E. Shook may publish in the future.

Co-authorship network of co-authors of Jennifer E. Shook

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer E. Shook. A scholar is included among the top collaborators of Jennifer E. Shook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer E. Shook. Jennifer E. Shook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lehman, Constance D., et al.. (2005). Clinical Experience with MRI-Guided Vacuum-Assisted Breast Biopsy. American Journal of Roentgenology. 184(6). 1782–1787. 102 indexed citations
2.
Lehman, Constance D. & Jennifer E. Shook. (2003). Position of Clip Placement After Vacuum-Assisted Breast Biopsy: Is a Unilateral Two-View Postbiopsy Mammogram Necessary?. The Breast Journal. 9(4). 272–276. 6 indexed citations
3.
Davis, Thomas P., Terrence J. Gillespie, Jennifer E. Shook, et al.. (1991). Changes in opioid receptor selectivity following processing of peptide E: Effect on gut motility. Gastroenterology. 100(6). 1603–1615. 5 indexed citations
4.
5.
Shook, Jennifer E., et al.. (1991). Spinally mediated opioid antidiarrheal effects. European Journal of Pharmacology. 193(1). 109–115. 9 indexed citations
6.
Brady, Kathleen T., R. Bruce Lydiard, J.C. Ballenger, et al.. (1991). CSF opioids in panic disorder. Biological Psychiatry. 30(5). 512–514. 10 indexed citations
7.
Afifi, Mostafa, et al.. (1990). Depression of Ventilatory Responses to Hypoxia and Hypercapnia After Pentamorphone. Anesthesia & Analgesia. 71(4). 377???383–377???383. 8 indexed citations
8.
Shook, Jennifer E., W. David Watkins, & Enrico M. Camporesi. (1990). Differential Roles of Opioid Receptors in Respiration, Respiratory Disease, and Opiate-induced Respiratory Depression. American Review of Respiratory Disease. 142(4). 895–909. 212 indexed citations
9.
Landis, Geoffrey A., George K. Lui, Jennifer E. Shook, et al.. (1989). Synthesis of highly .mu. and .delta. opioid receptor-selective peptides containing a photoaffinity group. Journal of Medicinal Chemistry. 32(3). 638–643. 13 indexed citations
10.
Shook, Jennifer E. & Thomas F. Burks. (1989). Psychoactive cannabinoids reduce gastrointestinal propulsion and motility in rodents.. Journal of Pharmacology and Experimental Therapeutics. 249(2). 444–449. 73 indexed citations
11.
Kramer, Thomas H., Jennifer E. Shook, Wieslaw Kazmierski, et al.. (1989). Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo.. Journal of Pharmacology and Experimental Therapeutics. 249(2). 544–551. 122 indexed citations
12.
Shook, Jennifer E., Wieslaw M. Kazmierski, Victor J. Hruby, & Thomas F. Burks. (1988). Precipitation of spinally mediated withdrawal signs by intrathecal administration of naloxone and the mu-receptor antagonist CTP in morphine-dependent mice.. PubMed. 81. 143–8. 4 indexed citations
13.
Kazmierski, Wieslaw M., William S. Wire, George K. Lui, et al.. (1988). Design and synthesis of somatostatin analogs with topographical properties that lead to highly potent and specific .mu. opioid receptor antagonists with greatly reduced binding at somatostatin receptors. Journal of Medicinal Chemistry. 31(11). 2170–2177. 106 indexed citations
14.
Sugg, Elizabeth E., Mariangela Serra, Jennifer E. Shook, et al.. (1988). Cholecystokinic activity of Nα‐hydroxysulfonyl‐[Nle28,31]CCK26‐33 analogues modified at the C‐terminal residue. International journal of peptide & protein research. 31(6). 514–519. 5 indexed citations
15.
Burks, Thomas F., et al.. (1988). II. Regulation of gastrointestinal function by multiple opioid receptors. Life Sciences. 43(26). 2177–2181. 55 indexed citations
16.
Shook, Jennifer E., et al.. (1988). Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.. Journal of Pharmacology and Experimental Therapeutics. 246(3). 1018–1025. 35 indexed citations
17.
Shook, Jennifer E., John T. Pelton, William S. Wire, et al.. (1987). Pharmacologic evaluation of a cyclic somatostatin analog with antagonist activity at mu opioid receptors in vitro.. Journal of Pharmacology and Experimental Therapeutics. 240(3). 772–777. 36 indexed citations
18.
Shook, Jennifer E., John T. Pelton, Victor J. Hruby, & Thomas F. Burks. (1987). Peptide opioid antagonist separates peripheral and central opioid antitransit effects.. Journal of Pharmacology and Experimental Therapeutics. 243(2). 492–500. 90 indexed citations
19.
Shook, Jennifer E., James F. Kachur, David A. Brase, & William L. Dewey. (1986). Morphine dependence and diabetes. II. Alterations of normorphine potency in the guinea-pig ileum and mouse vas deferens and of ileal morphine dependence by changes in glucose concentration.. Journal of Pharmacology and Experimental Therapeutics. 237(3). 848–852. 31 indexed citations
20.
Shook, Jennifer E., Mary Jeanne Kallman, Billy R. Martin, & William L. Dewey. (1984). Characterization of the interaction of pentazocine and tripelennamine: Drug discrimination and mu-receptor binding assay. Pharmacology Biochemistry and Behavior. 21(6). 877–881. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026